Aripiprazole (US brand name Abilify® and generic Aripiprix, zolonda) is a second-or third generation (atypical) antipsychotic.
FDA-approved indications
A. Oral
1. Schizophrenia
2. Acute treatment of manic and mixed episodes associated with bipolar I disorder
3. Adjunctive treatment of major depressive disorder
4. Irritability associated with autistic disorder
5. Treatment of Tourette’s disorder
B. Injectable
Agitation associated with schizophrenia or bipolar mania
Dosage
Schizophrenia (adults)
Initial: 10–15 mg/day
Recommended: 10–15 mg/day
Maximum: 30 mg/day
Schizophrenia (adolescents)
Initial: 2 mg/day
Recommended: 10 mg/day
Maximum: 30 mg/day
Bipolar mania (adults: monotherapy)
Initial: 15 mg/day
Recommended: 15 mg/day
Maximum: 30 mg/day
Bipolar mania (adults: adjunct to lithium or valproate)
Initial: 10–15 mg/day
Recommended: 15 mg/day
Maximum: 30 mg/day
Bipolar mania (pediatric patients: monotherapy or as an adjunct to lithium or valproate)
Initial: 2 mg/day
Recommended: 10 mg/day
Maximum: 30 mg/day
Major depressive disorder (adults: adjunct to antidepressants)
Initial: 2–5 mg/day
Recommended: 5–10 mg/day
Maximum: 15 mg/day
Irritability associated with autistic disorder (pediatric patients)
Initial: 2 mg/day
Recommended: 5–10 mg/day
Maximum: 15 mg/day
Tourette’s disorder (patients 50 kg)
Initial: 2 mg/day
Recommended: 10 mg/day
Maximum: 20 mg/day
Agitation associated with schizophrenia or bipolar mania (adults)
Initial: 9.75 mg/1.3 mL Injected IM
Maximum: 30 mg/day Injected IM
General Instructions:
1. Oral formulations may be administered once daily without regard to meals.
2. IM injection: Wait at least 2 hours between doses. Maximum daily dose 30 mg.
3. In patients who are known CYP2D6 poor metabolizers, prescribe half of the usual dose.
Dosage forms and strengths
Tablets (Abilify® and generic): 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg
Orally disintegrating tablets (Abilify® and generic): 10 mg and 15 mg
Oral solution (generic): 1 mg/mL
Injection (Abilify®): 9.75 mg/1.3 mL single-dose vial (7.5 mg/mL)